These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38760304)

  • 1. Gasdermin D palmitoylation: to cleave or not to cleave?
    Stine L; Humphries F
    Trends Immunol; 2024 Jun; 45(6):403-405. PubMed ID: 38760304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylation at a conserved cysteine residue facilitates gasdermin D-mediated pyroptosis and cytokine release.
    Liu Z; Li S; Wang C; Vidmar KJ; Bracey S; Li L; Willard B; Miyagi M; Lan T; Dickinson BC; Osme A; Pizarro TT; Xiao TS
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2400883121. PubMed ID: 38980908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for palmitoylation in pyroptosis.
    Sun Z; Hornung V
    Mol Cell; 2024 Jun; 84(12):2218-2220. PubMed ID: 38906113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A palmitoylation-depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis.
    Zhang N; Zhang J; Yang Y; Shan H; Hou S; Fang H; Ma M; Chen Z; Tan L; Xu D
    Nat Cell Biol; 2024 May; 26(5):757-769. PubMed ID: 38538834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis.
    Balasubramanian A; Hsu AY; Ghimire L; Tahir M; Devant P; Fontana P; Du G; Liu X; Fabin D; Kambara H; Xie X; Liu F; Hasegawa T; Xu R; Yu H; Chen M; Kolakowski S; Trauger S; Larsen MR; Wei W; Wu H; Kagan JC; Lieberman J; Luo HR
    Sci Immunol; 2024 Apr; 9(94):eadn1452. PubMed ID: 38530158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D.
    Du G; Healy LB; David L; Walker C; El-Baba TJ; Lutomski CA; Goh B; Gu B; Pi X; Devant P; Fontana P; Dong Y; Ma X; Miao R; Balasubramanian A; Puthenveetil R; Banerjee A; Luo HR; Kagan JC; Oh SF; Robinson CV; Lieberman J; Wu H
    Nature; 2024 Jun; 630(8016):437-446. PubMed ID: 38599239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction.
    Zhuang Z; Gu J; Li BO; Yang L
    Transl Res; 2024 Feb; 264():66-75. PubMed ID: 37769810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications.
    Liu Z; Chen Y; Mei Y; Yan M; Liang H
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into Gasdermin D pore formation.
    Kappelhoff S; Margheritis EG; Cosentino K
    Biochem Soc Trans; 2024 Apr; 52(2):681-692. PubMed ID: 38497302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.
    Kopp A; Hagelueken G; Jamitzky I; Moecking J; Schiffelers LDJ; Schmidt FI; Geyer M
    Nat Commun; 2023 Dec; 14(1):7923. PubMed ID: 38040708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylation promotes pores.
    Foley JF
    Sci Signal; 2024 Jun; 17(842):eadr1306. PubMed ID: 38917221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation.
    Jiang X; Zhang X; Cai X; Li N; Zheng H; Tang M; Zhu J; Su K; Zhang R; Ye N; Peng J; Zhao M; Wu W; Yang J; Ye H
    Sci Adv; 2024 Feb; 10(6):eadi9284. PubMed ID: 38324683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis.
    Shi Y; Yang Y; Xu W; Shi D; Xu W; Fu X; Lv Q; Xia J; Shi F
    Cell Death Dis; 2022 Feb; 13(2):106. PubMed ID: 35115505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein engineering reveals that gasdermin A preferentially targets mitochondrial membranes over the plasma membrane during pyroptosis.
    Kondolf HC; D'Orlando DA; Dubyak GR; Abbott DW
    J Biol Chem; 2023 Feb; 299(2):102908. PubMed ID: 36642180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications.
    Mulla J; Katti R; Scott MJ
    Organogenesis; 2023 Dec; 19(1):2177484. PubMed ID: 36967609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Molecular Correlations of GSDMD with Pyroptosis inAlzheimer's Disease.
    Song T; Chen Y; Li C; Yao Y; Ma S; Shang Y; Cheng J
    Comb Chem High Throughput Screen; 2024; 27(14):2125-2139. PubMed ID: 39099451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bacterial toxin co-opts caspase-3 to disable active gasdermin D and limit macrophage pyroptosis.
    Wright SS; Wang C; Ta A; Havira MS; Ruan J; Rathinam VA; Vanaja SK
    Cell Rep; 2024 Apr; 43(4):114004. PubMed ID: 38522070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gasdermins and their role in immunity and inflammation.
    Orning P; Lien E; Fitzgerald KA
    J Exp Med; 2019 Nov; 216(11):2453-2465. PubMed ID: 31548300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSDMD in regulated cell death: A novel therapeutic target for sepsis.
    Ma X; Lin Y; Zhang L; Miao S; Zhang H; Li H; Fu X; Han L; Li P
    Int Immunopharmacol; 2024 Jun; 135():112321. PubMed ID: 38795599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review.
    Xiaodong L; Xuejun X
    Int Ophthalmol; 2023 Apr; 43(4):1405-1411. PubMed ID: 36068399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.